Healthtech Solutions, Inc./UT Overview
Industry: Health Information Services
Sector: Healthcare
Healthtech Solutions, Inc., through its subsidiaries, operates as a life sciences company. It focuses on the development of wound care products for acute and chronic wounds, including AmnioBind, a placental membrane allograft for burns and non-healing wounds, such as diabetic foot ulcers. The company also engages in the development of ultrasound imaging and artificial intelligence-based image analysis software for the applications in treatment of chest and musculoskeletal system. In addition, it is developing software technology that compares a healthy heart rhythm electronic signal with a damaged heart's signal that derives an electronic signal representing the curative waveform. The company was founded in 2018 and is based in Tuckahoe, New York.
Healthtech Solutions, Inc./UT is evaluated using Mavefund's quality framework: growing earnings, durable profit margins, conservative leverage, strong return on equity, and disciplined share repurchases.
Score
Price History & Performance
Review Healthtech Solutions, Inc./UT in context before unlocking the interactive price chart, financial overlays, and downloadable ratio tables.
Recent News
Healthtech Solutions, Inc./UT Competitors
Healthtech Solutions, Inc./UT operates in the Health Information Services industry within the Healthcare sector. Unlock the full page to compare peer rankings, valuation quality, profitability, leverage, and growth trends.
Earnings Per Share
EPS quality is one of the core Mavefund signals. Sign up to continue into the detailed EPS, ROE, margin, share buyback, leverage, and financial ratio analysis.
Continue the analysis
Sign up to unlock ROE, net margin, share buyback, leverage, financial ratios, peer charts, and downloads.
View plans